SEC Form 4 · accession 0001615774-16-007378
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher U Missling
Officer — President, CEO & Treasurer · Director
Period of report
Sep 22, 2016
Accepted (ET)
Sep 26, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.28 | Sep 22, 2016 | A | 500,000 | A | Sep 22, 2016 | Sep 22, 2026 | Common Stock | 500,000 | 500,000 | D |